​

Funding Round

Series A - BlackThorn Therapeutics

Series A - BlackThorn Therapeutics

Investment Firm

Overview

BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.

Announced Date

Oct 20, 2016

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

ARCH Venture Partners

ARCH Venture Partners

ARCH Venture Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorAltitude Life Science Ventures
Participant InvestorJohnson & Johnson Robotics and Digital Solutions
Participant InvestorAlexandria Real Estate Equities
Participant InvestorARCH Venture Partners
Participant InvestorMercury

Round Details and Background

BlackThorn Therapeutics raised $40000000 on 2016-10-20 in Series A

BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 13, 2019
Series B - BlackThorn Therapeutics
11-76.0M
Jun 20, 2017
Grant - BlackThorn Therapeutics
1-8.0M
Jan 05, 2017
Series A - BlackThorn Therapeutics
2-14.0M
Oct 20, 2016
Series A - BlackThorn Therapeutics
5-40.0M

Recent Activity

There is no recent news or activity for this profile.